Company Analysis

ImmunityBio, Inc. (IBRX)

Nasdaq: IBRX · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2005
Grade5.5
◀ Past 5.2● Present 5.1▶ Future 6.2
1 est.

Filings

238 filings since 2017 beside 223 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
2546754556464965
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Dec 15, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 19, 2025.SEC letters: 3 in the last 36 months, the newest Apr 30, 2024.
Insider forms 223

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 10-Q Quarterly report Sep 30, 2026
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 6, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 4, 2026 10-Q Quarterly report Jun 30, 2026
Aug 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 30, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jul 29, 2026
Jun 10, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 9, 2026
May 18, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report May 14, 2026
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEF 14A Proxy statement Jun 9, 2026
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 6, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 31, 2026 8-K items 1.01, 2.03, 7.01, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Investor disclosure (Regulation FD); Other event · Current report Mar 30, 2026
Feb 25, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 23, 2026 10-K Annual report Dec 31, 2025
Feb 23, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 18, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 26, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jan 23, 2026
Jan 15, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 14, 2026 8-K items 8.01, 9.01 Other event · Current report
Dec 29, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Dec 23, 2025
Dec 29, 2025 424B5 Shelf offering
Dec 15, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Dec 10, 2025
Dec 12, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 10, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 5, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 8-K items 2.02, 9.01 Results released · Current report Nov 4, 2025
Oct 20, 2025 DEF 14C Information statement
Oct 8, 2025 PRE 14C Preliminary information statement
Aug 8, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 28, 2025 424B5 Shelf offering
Jul 25, 2025 8-K items 1.01, 2.02, 7.01, 8.01, 9.01 Major agreement signed; Results released; Investor disclosure (Regulation FD); Other event · Current report Jul 24, 2025
Jun 23, 2025 S-8 Employee stock plan registration
40 of 238 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton IBRX · research, not advice